Phenylephrine/ketorolac
Phenylephrine/ketorolac, sold under the brand name Omidria, is a combination drug used during cataract surgery or intraocular lens replacement to prevent intraoperative miosis and to reduce postoperative pain. It contains phenylephrine and ketorolac.Phenylephrine/ketorolac was approved for medical use in the United States in May 2014, and in the European Union in July 2015.

References
External links
"Ketorolac mixture with phenylephrine". Drug Information Portal. U.S. National Library of Medicine.